2024-11-19 | Edwards Lifesciences Corporation is being sued for violating securities laws and law firm Schall wants the affected shareholders to contact them | NYSE:EW

LOS ANGELES, CA / ACCESSWIRE / November 19, 2024 / The Schall Law Firm, a national shareholder rights law firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation (“Edwards Lifesciences” or “the Company”) (NYSE:EW) for violations of 10(b) and 20(a) ). ) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), are encouraged to contact the Company before December 13, 2024.

Are you a shareholder and have you suffered a loss? click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights, free of charge. You can also reach us via the company website: www.schallfirm.comor by email at [email protected].

In this case, the class has not yet been certified and until certification occurs, you will not be represented by an attorney. If you choose to take no action, you may remain an absent class member.

According to the complaint, the company made false and misleading statements to the marketplace. Edwards Lifesciences misled investors about its expected fiscal year 2024 revenues, specifically regarding the performance of its Transcatheter Aortic Valve Replacement (“TAVR”) platform. The company claimed to be heavily involved in the TAVR platform and claimed it could achieve penetration into new markets. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Edwards Lifesciences, investors suffered.

Join the cause to recover your losses.

The Schall Law Firm represents investors worldwide and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered attorney advertising in some jurisdictions under applicable law and ethical rules.

CONTACT:

Schall law firm

Brian Schall, Esq.

310-301-3335

[email protected]

www.schallfirm.com

SOURCE: Schall law firm

View the original press release at accesswire.com